Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib.
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRC
- Status
- UNKNOWN
- Phase
- PHASE2
Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)
- Status
- COMPLETED
- Phase
- PHASE1
Mix Vaccine for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical Trials
- Status
- UNKNOWN
- Phase
- N/A
Atezolizumab Monotherapy vs Atezolizumab Plus Cobimetinib in Liver Metastases From Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers
- Status
- WITHDRAWN
- Phase
- PHASE2
Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).
- Status
- COMPLETED
- Phase
- PHASE3
Circulating Tumor Cells in mCRC for Liver Resection
- Status
- UNKNOWN
- Phase
- N/A
Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Pattern of Use of Bevacizumab or Cetuximab + FOLFIRI Regimen as First-line Treatment in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A